Gilead Sciences Stock Analysis (NASDAQ:GILD)
Gilead Sciences Analysis Video
View Gilead Sciences stock analysis video. This is our GILD analyst opinion covering the buy and sell arguments for GILD stock.
Gilead Sciences, Inc. Stock Rating (4.1/5)
Our Gilead Sciences stock opinion is based on fundamentals of the company. This Gilead Sciences stock analysis is based on latest Q1 earnings for 2017. The stock price analysis takes into account a company's valuation metrics.
Should you buy GILD stock?
- Gilead Sciences had a healthy average operating margin of 57.6% over the last 4 quarters.
- LTM Net margins were good at 43.4% for Gilead Sciences.
- The price to earnings multiple of 6.1 is attractive when compared with the industry average PE ratio of 22.4.
- When compared with the Medical-Biomed-Genetics industry average PS ratio of 4.5, the price-to-sales ratio of 2.9 for GILD stock is attractive.
- Gilead Sciences has an attractive ROIC (Return on Invested Capital) of 45.5%
- Gilead Sciences has a good Return On Equity (ROE) of 72%.
- The company has a good Free Cash Flow (FCF) margin of 43.2%.